Maryland

Effective Saturday, August 10, the Medicaid Pharmacy Program announced brand Revatio® suspension is preferred over its generic equivalent (sildenafil). Claims for brand Revatio® suspension must be submitted with DAW 6 code and will be priced appropriately. A Department of Health Medwatch form will not be required. Claims with any other DAW code will reject.

Also in Maryland… Effective Saturday, August 10, the Medicaid Pharmacy Program announced all strengths of brand Lyrica® must be submitted with DAW 6 code and will be priced appropriately. A Department of Health Medwatch form will not be required. Claims with any other DAW code will be rejected.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-08-08T09:35:41-04:00August 8, 2019|Maryland|

Maryland

The Department of Health, Board of Pharmacy, published the following rules effective May 20, 2019.

  • Final rule amends regulations under COMAR 10.34.09 to eliminate the administrative fee for board reviews of pharmacy technician training programs that include a didactic portion identical to an already approved program.
  • Final rule amends, adopts and repeals regulations under COMAR 10.34.30 to codify existing policies concerning changes of name, ownership or location for permitted pharmacies and wholesale distributions facilities. The rule also allows the board to close an incomplete application after one year.
  • Final rule amends regulations under COMAR 10.34.05 to require pharmacy permit holders to report a significant loss of controlled substances in addition to the requirement to report thefts.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-05-29T14:15:23-04:00May 29, 2019|Maryland|

Maryland

Gov. Larry Hogan (R) has signed HB 316 into law, which will require all healthcare practitioners to report immunizations they administer to Immunet, the state’s vaccine registry. The law was a priority of the Maryland Association of Chain Drug Stores as a precursor to expanding pharmacists’ immunization authority and will be effective Tuesday, October 1.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-06-25T10:12:39-04:00May 16, 2019|Maryland|

Maryland

NACDS reminds members that beginning Saturday, June 1, all dispensers must begin reporting data to the state’s new prescription drug monitoring program vendor, RxGov. The Department of Health is urging pharmacies to begin this process as soon as possible as they have experienced delays in uploading of data to the new product.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-05-14T09:50:53-04:00May 9, 2019|Maryland|

Maryland

Legislation considered a prelude to efforts to further expanding pharmacists’ immunization authority is on its way to Gov. Larry Hogan (R). HB 316, sponsored by Del. Ariana Kelly (D), will require all health care providers who administer a vaccine to report it to the Maryland immunization registry, ImmuNet. Once signed, HB 316 will be effective Tuesday, October 1. The legislation was an initiative of the Maryland Association of Chain Drug Stores. NACDS thanks the Maryland Retail Association for its on-the-ground work in advancing this bill.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-04-24T08:52:30-04:00April 18, 2019|Maryland|

Maryland

The Medicaid Pharmacy Program announced, effective Monday, January 28, Kapyay® ER will no longer be preferred over its generic equivalent. The current Preferred Drug List (PDL) is available on the website.

Also in Maryland…The Medicaid Pharmacy Program announced, effective Friday, February 15, Reyataz® capsules will no longer be preferred over its generic equivalent.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-02-05T14:12:42-05:00January 25, 2019|Maryland|

Maryland

Effective January 1, 2019, pharmacists are able to prescribe certain contraceptives to patients and be reimbursed under Medicaid and the state’s Children’s Health Insurance Program. The Board of Pharmacy has published online guidance on complying with the law and the required patient screening forms

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-01-16T10:18:30-05:00January 10, 2019|Maryland|

Maryland

The Department of Health (MDH) is seeking retail pharmacists to serve on the Drug Utilization Review (DUR) Board. New members will be appointed in January 2019 and applications are due Friday, September 14. Information concerning duties and powers of the board can be found in the latest issue of the Maryland Register. Interested applicants must submit a formal application through the MDH’s Office of Appointments and Executive Nominations. For further information or questions, contact Kim Bennardi of MDH.

2018-09-14T08:26:09-04:00September 13, 2018|Maryland|

Maryland

The Maryland Medicaid Pharmacy Program will be conducting a stakeholder meeting on Wednesday, June 13 in Baltimore to discuss the mandatory pharmacy cost of dispensing survey that will be conducted this summer. All providers that participate in the Maryland Medicaid Pharmacy Program are invited to attend.

For more information, contact NACDS’ Sandra Guckian at 703-837-4195.

2018-05-25T10:38:59-04:00May 17, 2018|Maryland|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top